Promentis: Promentis Pharmaceuticals to Present at the 11th Anniversary CNS Summit | Markets Insider
MILWAUKEE, Oct. 31, 2020 /PRNewswire/ -- Promentis Pharmaceuticals, Inc., a privately held biopharmaceutical company developing innovative therapi...
Read full article »
Promentis researches, develops and commercializes novel therapies for the treatment of central nervous system disorders.
Read more